Sun Pharma Advanced Research Company informs about press release

22 Sep 2020 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed it has enclosed the Press Release titled ‘SPARC Licenses Commercialization Rights of ElepsiaTM XR to Tripoint Therapeutics’ being released by the Company on 22nd September 2020, which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.


Sun Pharma Adv. Res Share Price

134.45 0.70 (0.52%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 643.75
Indegene 519.25
CMS Info Systems 339.55
Sagility 52.19
Smartworks Coworking 476.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×